SnoN promotes mitogenic transformation of breast and lung cancer cell lines in vitro and tumor growth in vivo through downregulating JunB and CDKN1A (Cyclin Dependent Kinase Inhibitor 1A, also known as p21CIP1), suggesting that it may facilitate the establishment of primary tumor colonies by enhancing cell growth. Here, CDKN1A is linked to lung carcinoma.